Tradestie Institutional Equity Comparison Engine

EVEX vs SRTA โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

SRTA Overall Edge

SRTA Captures Institutional Edge (3โ€“1 Pillars ยท 6โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Strata Critical Medical, Inc. Class A Common Stock (SRTA) driven by superior Valuation, Momentum & Technical, Options & Structure while EVEX counters with relative strength in Growth & Margin. Fundamentally, EVEX trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus SRTA at 71.1x Forward P/E and -4.7% operating margin (+50.3% YoY). In options structure, EVEX sits in UNCLASSIFIED (50th %ile IV; Dealer Gamma Walls on Pro) against SRTA sits in CONSOLIDATION (8th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner SRTA
EVEX N/M vs SRTA 71.1x Fwd P/E
Growth & Margin Winner EVEX
Op Margin 0.0% vs -4.7% ยท YoY +0.0% vs +50.3%
Momentum & Technical Winner SRTA
1Y -59.1% vs +9.9% ยท 52W Pos 8% vs 56%
Options & Structure Winner SRTA
UNCLASSIFIED (50th %ile IV) vs CONSOLIDATION (8th %ile IV)
EVEX NYSE
Eve Holding, Inc.
Aircraft
$1.70
+2.41% 1D
Market Cap $597.7M
1M Return +4.94%
1Y Return -59.13%
Forward P/E N/M
Unified AI Score
41.3 / 100 SELL
Tech 20.0 Fund 45.0 Flow 50.0 Mom 50.0
SRTA NASDAQ
Strata Critical Medical, Inc. Class A Common Stock
Air Transportation, Nonscheduled
$5.38
-2.45% 1D
Market Cap $515.4M
1M Return +18.39%
1Y Return +9.92%
Forward P/E 71.1x
Unified AI Score
29.9 / 100 SELL
Tech 50.0 Fund 31.0 Flow 57.0 Mom 44.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: EVEX -59.13% SRTA +9.92% Spread: +69.05 pp (SRTA Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
EVEX TTM Op. Margin: 0.0% SRTA TTM Op. Margin: -4.7%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on EVEX vs SRTA. Trailing 12-month operating profitability (EVEX 0.0% vs SRTA -4.7%) and valuation multiples (EVEX N/M vs SRTA 71.1x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: EVEX (4) vs SRTA (6)
Institutional Metric EVEX SRTA Criterion Row Winner
Market Capitalization Scale $597.7M $515.4M Larger Scale EVEX
Trailing P/E Ratio Valuation N/M 138.9x Lower Multiple SRTA
Forward P/E Ratio Valuation N/M 71.1x Lower Multiple SRTA
Revenue Growth (YoY) Growth +0.0% +50.3% Higher Growth SRTA
Operating Margin (TTM) Profitability 0.0% -4.7% Higher Margin EVEX
Net Profit Margin Profitability 0.0% -8.8% Higher Margin EVEX
Return on Equity (ROE) Capital Efficiency -300.9% -7.5% Higher ROE SRTA
52-Week Range Position Momentum 8% ($1โ€“$5) 56% ($4โ€“$6) Stronger Trend SRTA
Beta / 30D Volatility Risk Regime 2.71ฮฒ ยท 96% Vol 1.97ฮฒ ยท 82% Vol Lower Realized Risk SRTA
Unified Institutional Score Composite Signal 41.3 / 100 (SELL) 29.9 / 100 (SELL) Higher Composite EVEX

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full EVEX vs SRTA Buy Guide
EVEX UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 50th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live EVEX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
SRTA CONSOLIDATION
119d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 8th %ile
IV Regime Compressed (<25th %ile)
Live SRTA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither EVEX nor SRTA registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.